GRANADILLO PEDRO P 5

5 · ROCKET PHARMACEUTICALS, INC. · Filed Feb 16, 2021

Form 5

Period: 2020-12-31

Director

Transactions

Gift
Stock Option (Right to Buy)
2020-12-28−30,000→ 0 total
Exercise: $14.56Exp: 2029-01-28→ Common Stock (30,000 underlying)
Gift
Stock Option (Right to Buy)
2020-12-28+40,000→ 40,000 total(indirect: By Trust)
Exercise: $18.75Exp: 2028-03-29→ Common Stock (40,000 underlying)
Gift
Stock Option (Right to Buy)
2020-12-28+30,000→ 30,000 total(indirect: By Trust)
Exercise: $14.56Exp: 2029-01-28→ Common Stock (30,000 underlying)
Gift
Stock Option (Right to Buy)
2020-12-28−40,000→ 0 total
Exercise: $18.75Exp: 2028-03-29→ Common Stock (40,000 underlying)
Gift
Stock Option (Right to Buy)
2020-12-28−20,000→ 0 total
Exercise: $19.90Exp: 2030-06-16→ Common Stock (20,000 underlying)
Gift
Stock Option (Right to Buy)
2020-12-28+20,000→ 20,000 total(indirect: By Trust)
Exercise: $19.90Exp: 2030-06-16→ Common Stock (20,000 underlying)

Footnotes (3)

[F1]This option represents a right to purchase a total of 30,000 shares of the Issuer's Common Stock, all of which are currently vested and exercisable.
[F2]This option represents a right to purchase a total of 40,000 shares of the Issuer's Common Stock, 37,778 of which are currently vested and exercisable, with the remaining 2,222 shares vesting in equal monthly installments on each of February 28, 2021 and March 29, 2021.
[F3]This option represents a right to purchase a total of 20,000 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 16, 2021.

Documents

1 file